Company: PFSA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076861
Chunk: 4

Company: Profusa, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
    Common stock  
    Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 

    Balance as of December 31, 2023 
     5,193,750  
    $519  
    $—  
    $(3,459,829) 
    $(3,459,310)

    Accretion of common stock to redemption value 
     —  
     —  
     —  
     (205,732) 
     (205,732)

    Excise tax payable attributable to redemption of common stock 
     —  
     —  
     —  
     (10,884) 
     (10,884)

    Net loss 
     —  
     —  
     —  
     (820,277) 
     (820,277)

    Balance as of March 31, 2024 (unaudited) 
     5,193,750  
     519  
     —  
     (4,496,722) 
     (4,496,203)

    Accretion of common stock to redemption value 
     —  
     —  
     —  
     (181,330) 
     (181,330)

    Net loss 
     —  
     —  
     —  
     (397,487) 
     (397,487)

    Balance as of June 30, 2024 (unaudited) 
     5,193,750  
    $519  
    $—  
    $(5,075,539) 
    $(5,075,020)

The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.

3

PROFUSA, INC. (F/K/A NORTHVIEW ACQUISITION
CORPORATION)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS

    For the Six Months Ended June 30, 

    2025  
    2024 
  
    Cash flows from operating activities: 

    Net loss 
    $(9,316,786) 
    $(1,217,764)
  
    Adjustments